These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 18322196)

  • 21. Altered Marginal Zone B Cell Selection in the Absence of IκBNS.
    Ádori M; Pedersen GK; Ádori C; Erikson E; Khoenkhoen S; Stark JM; Choi JH; Dosenovic P; Karlsson MCI; Beutler B; Karlsson Hedestam GB
    J Immunol; 2018 Jan; 200(2):775-787. PubMed ID: 29222168
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activation of marginal zone B cells from lupus mice with type A(D) CpG-oligodeoxynucleotides.
    Brummel R; Lenert P
    J Immunol; 2005 Feb; 174(4):2429-34. PubMed ID: 15699180
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TLR9-activating DNA up-regulates ZAP70 via sustained PKB induction in IgM+ B cells.
    Bekeredjian-Ding I; Doster A; Schiller M; Heyder P; Lorenz HM; Schraven B; Bommhardt U; Heeg K
    J Immunol; 2008 Dec; 181(12):8267-77. PubMed ID: 19050243
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Separation of the New Zealand Black genetic contribution to lupus from New Zealand Black determined expansions of marginal zone B and B1a cells.
    Atencio S; Amano H; Izui S; Kotzin BL
    J Immunol; 2004 Apr; 172(7):4159-66. PubMed ID: 15034028
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bone marrow dendritic cell-mediated regulation of TLR and B cell receptor signaling in B cells.
    Sindhava VJ; Tuna H; Gachuki BW; DiLillo DJ; Avdiushko MG; Onami TM; Tedder TF; Cohen DA; Bondada S
    J Immunol; 2012 Oct; 189(7):3355-67. PubMed ID: 22942427
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Peritoneal cavity B cells are precursors of splenic IgM natural antibody-producing cells.
    Kawahara T; Ohdan H; Zhao G; Yang YG; Sykes M
    J Immunol; 2003 Nov; 171(10):5406-14. PubMed ID: 14607944
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cutting edge: selection of B lymphocyte subsets is regulated by natural IgM.
    Baker N; Ehrenstein MR
    J Immunol; 2002 Dec; 169(12):6686-90. PubMed ID: 12471099
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Marginal zone B cells transport IgG3-immune complexes to splenic follicles.
    Zhang L; Ding Z; Xu H; Heyman B
    J Immunol; 2014 Aug; 193(4):1681-9. PubMed ID: 25015822
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The mucosal adjuvant macrophage-activating lipopeptide-2 directly stimulates B lymphocytes via the TLR2 without the need of accessory cells.
    Borsutzky S; Kretschmer K; Becker PD; Mühlradt PF; Kirschning CJ; Weiss S; Guzmán CA
    J Immunol; 2005 May; 174(10):6308-13. PubMed ID: 15879130
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Artemisinin attenuates IgM xenoantibody production via inhibition of T cell-independent marginal zone B cell proliferation.
    Liu L; Zhao J; Li A; Yang X; Sprangers B; Li S
    J Leukoc Biol; 2021 Mar; 109(3):583-591. PubMed ID: 32542769
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transgenic expression of a human polyreactive Ig expressed in chronic lymphocytic leukemia generates memory-type B cells that respond to nonspecific immune activation.
    Widhopf GF; Brinson DC; Kipps TJ; Tighe H
    J Immunol; 2004 Feb; 172(4):2092-9. PubMed ID: 14764674
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhanced Toll-like receptor (TLR) responses of TNFR-associated factor 3 (TRAF3)-deficient B lymphocytes.
    Xie P; Poovassery J; Stunz LL; Smith SM; Schultz ML; Carlin LE; Bishop GA
    J Leukoc Biol; 2011 Dec; 90(6):1149-57. PubMed ID: 21971520
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Attenuating regulatory T cell induction by TLR agonists through inhibition of p38 MAPK signaling in dendritic cells enhances their efficacy as vaccine adjuvants and cancer immunotherapeutics.
    Jarnicki AG; Conroy H; Brereton C; Donnelly G; Toomey D; Walsh K; Sweeney C; Leavy O; Fletcher J; Lavelle EC; Dunne P; Mills KH
    J Immunol; 2008 Mar; 180(6):3797-806. PubMed ID: 18322186
    [TBL] [Abstract][Full Text] [Related]  

  • 34. FcμR in human B cell subsets in primary selective IgM deficiency, and regulation of FcμR and production of natural IgM antibodies by IGIV.
    Gupta S; Agrawal S; Gollapudi S; Kubagawa H
    Hum Immunol; 2016 Dec; 77(12):1194-1201. PubMed ID: 27751883
    [TBL] [Abstract][Full Text] [Related]  

  • 35. B-1 B cell IgM antibody initiates T cell elicitation of contact sensitivity.
    Askenase PW; Tsuji RF
    Curr Top Microbiol Immunol; 2000; 252():171-7. PubMed ID: 11125474
    [TBL] [Abstract][Full Text] [Related]  

  • 36. B cells from mice prematurely expressing human complement receptor type 2 are unresponsive to T-dependent antigens.
    Birrell L; Kulik L; Morgan BP; Holers VM; Marchbank KJ
    J Immunol; 2005 Jun; 174(11):6974-82. PubMed ID: 15905540
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Generation of protective T cell-independent antiviral antibody responses in SCID mice reconstituted with follicular or marginal zone B cells.
    Guay HM; Mishra R; Garcea RL; Welsh RM; Szomolanyi-Tsuda E
    J Immunol; 2009 Jul; 183(1):518-23. PubMed ID: 19542462
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Splenic marginal zone dendritic cells mediate the cholera toxin adjuvant effect: dependence on the ADP-ribosyltransferase activity of the holotoxin.
    Grdic D; Ekman L; Schön K; Lindgren K; Mattsson J; Magnusson KE; Ricciardi-Castagnoli P; Lycke N
    J Immunol; 2005 Oct; 175(8):5192-202. PubMed ID: 16210624
    [TBL] [Abstract][Full Text] [Related]  

  • 39. NF-κB2/p100 deficiency impairs immune responses to T-cell-independent type 2 antigens.
    Krljanac B; Weih D; Jacobsen ID; Hu D; Koliesnik I; Reppe K; Witzenrath M; Weih F
    Eur J Immunol; 2014 Mar; 44(3):662-72. PubMed ID: 24242887
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evidence that marginal zone B cells possess an enhanced secretory apparatus and exhibit superior secretory activity.
    Gunn KE; Brewer JW
    J Immunol; 2006 Sep; 177(6):3791-8. PubMed ID: 16951340
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.